Introducing CoverScan

The product of our latest research is CoverScan, a noninvasive imaging tool to assess the health of six organs using a single scan. We developed this product over a two-year journey working alongside our long COVID study community participants.  

This work has enabled us to assess multi-organ impairment in patients affected by long COVID and other conditions, whilst also investigating the inequalities in access  and provision of high-quality long COVID care. 

Perspectum’s Prof. Sir Mike Brady, Dr. Rajarshi Banerjee, and Dr. Cat Kelly are team members of the largest long COVID clinical study to-date — STIMULATE-ICP — led by University College London Hospitals NHS Trust and University College London, together with researchers, health professionals, patients, and industry partners from over 30 organizations.  

LEARN MORE ABOUT COVERSCAN

Explore our research and innovation initiatives

Publications

Explore our library of peer-reviewed clinical evidence, including our landmark paper on mpMRI as a predictive tool for clinical outcomes.

learn more

Research projects

Explore our innovative solutions to the problems facing the healthcare sector and their patients.

Learn More

Join our research network

Perspectum invests heavily in research studies focusing on the development and translation of innovative precision medicine technologies using advanced imaging and genetics. 

Study participants make our research possible. Your experiences and understanding of your health are invaluable, helping us understand how we can help improve the care and management of your health.

JOIN OUR RESEARCH NETWORK